A Clinical Trial of the ACYW135 Group Meningococcal Polysaccharide-Conjugated Vaccine (CRM197 Vector)

by | Aug 3, 2026 | Clinical Trials | 0 comments

​ Conditions: Epidemic Meningitis

Interventions: Other: Previously vaccinated with MCV4 (CanSino); Other: Previously vaccinated with MPSV4 (LvZhu)

Sponsors: CanSino Biologics Inc.

Not yet recruiting Conditions: Epidemic Meningitis
Interventions: Other: Previously vaccinated with MCV4 (CanSino); Other: Previously vaccinated with MPSV4 (LvZhu)
Sponsors: CanSino Biologics Inc.
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *